JD Vance accuses Denmark of failing to keep Greenland secure as he slams European allies

OpenAI foresees revenue tripling this year to $12.7 billion, CNBC has confirmed.

While the “Magnificent Seven” helped lead the market higher last year, there are other stocks investors should eye for 2025 instead, according to Piper Sandler.

Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.